Microbiome hypothesis: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
m (Text replacement - "r|author" to "r |author")
m (Text replacement - "|last2=" to " | last2 = ")
Line 9: Line 9:


*2018, Does the [[microbiome]] and virome contribute to [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]?<ref name="Newberry, 2018" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843715/ (Full Text)]
*2018, Does the [[microbiome]] and virome contribute to [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]?<ref name="Newberry, 2018" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843715/ (Full Text)]
*2018, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host [[metabolism]], [[gene expression]] and [[Immune system|immunity]]<ref>{{Cite journal | last = Proal|first=Amy|author-link=Amy Proal|last2=Marshall|first2=Trevor |author-link2=Trevor Marshall|date=Nov 2018|title=Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression and immunity|url=https://www.frontiersin.org/articles/10.3389/fped.2018.00373/full|journal=Frontiers in Pediatrics|volume=|issue=|pages=|quote=|via=|doi=10.3389/fped.2018.00373}}</ref> [https://www.frontiersin.org/articles/10.3389/fped.2018.00373/full (Abstract)]
*2018, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host [[metabolism]], [[gene expression]] and [[Immune system|immunity]]<ref>{{Cite journal | last = Proal|first=Amy|author-link=Amy Proal | last2 = Marshall|first2=Trevor |author-link2=Trevor Marshall|date=Nov 2018|title=Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression and immunity|url=https://www.frontiersin.org/articles/10.3389/fped.2018.00373/full|journal=Frontiers in Pediatrics|volume=|issue=|pages=|quote=|via=|doi=10.3389/fped.2018.00373}}</ref> [https://www.frontiersin.org/articles/10.3389/fped.2018.00373/full (Abstract)]


==See also==
==See also==

Revision as of 11:44, October 17, 2022

Theory[edit | edit source]

Evidence[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. Navaneetharaja, Navena; Griffiths, Verity; Wileman, Tom; Carding, Simon R. (2016), "A Role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)?", Journal of Clinical Medicine, 5 (6): 55, doi:10.3390/jcm5060055
  2. Newberry, F.; Hsieh, S.-Y.; Wileman, T.; Carding, S. R. (2018), "Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome?", Clinical Science, 132 (5): 523–542, doi:10.1042/CS20171330
  3. Proal, Amy; Marshall, Trevor (November 2018). "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression and immunity". Frontiers in Pediatrics. doi:10.3389/fped.2018.00373.